Hide AAs |
Bloc 1 | Hours (*) | Term | Credits | Weight. |
| HT(*) | HTPE(*) | HTPS(*) | HD(*) | HR(*) | Total | |
| Enseignements obligatoires communs | | | | | | | | 10 | |
| | | | | | | | | | |
| | UM-M1-BIOMED-016-M Scientific Redaction & Communication | 15 | 0 | 220 | 0 | 0 | 235 | Q2 | 10 | 10 |
| | | M-DOYM-124 Scientific Redaction & Communication | | | | | | | | | |
| | | V-LANG-758 Giving Scientific Presentations (preparatory workshops) | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| Enseignements optionnels communs | | | | | | | | 26 | |
| | | | | | | | | | |
| | UM-M1-BIOMED-003-M Comparative Physiology | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-DOYM-010 Comparative physiology | | | | | | | | | |
| | UM-M1-BIOMED-008-M Animal Testing Training | 68 | 12 | 0 | 0 | 0 | 80 | Q1 | 8 | 8 |
| | | M-PHPH-003 Training in animal experimentation | | | | | | | | | |
| | UM-M1-BIOMED-017-M Cellular Biology of Cancer | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-ANBC-004 Cellular Biology of Cancer | | | | | | | | | |
| | UM-M1-BIOMED-018-M Preclinical Models in Oncology | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-BIMO-028 Preclinical Models in Oncology | | | | | | | | | |
| | UM-M1-BIOMED-019-M Nuclear Receptors | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-DOYM-023 Nuclear Receptors | | | | | | | | | |
| | UM-M1-BIOMED-020-M Eléments d'immunologie clinique et expérimentale | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-DOYM-002 Elements of clinical and experimental immunology | | | | | | | | | |
| | UM-M1-BIOMED-021-M Histologie des organes des sens | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-HIST-003 Histology of sense organs | | | | | | | | | |
| | | M-HIST-004 Embryogenèse de l'oeil | | | | | | | | | |
| | UM-M1-BIOMED-022-M Neuropharmacology | 30 | 0 | 0 | 0 | 0 | 30 | Q1 | 4 | 4 |
| | | M-DOYM-026 Neuropharmacology | | | | | | | | | |
| | UM-M1-BIOMED-023-M Voies intracellulaires de communication et maladies métaboliques | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-BHTO-005 Voies intracellulaires de communication et maladies métaboliques | | | | | | | | | |
| | UM-M1-BIOMED-025-M Pharmacologie spéciale | 15 | 0 | 10 | 0 | 0 | 25 | Q1,Q2 | 2 | 2 |
| | | M-DOYM-042 Special pharmacology | | | | | | | | | |
| | | M-DOYM-114 Pharmacologie spéciale - Travaux personnels | | | | | | | | | |
| | UM-M1-BIOMED-026-M Méthodes de ciblage moléculaire et applications biomédicales de l'imagerie moléculaire | 22 | 0 | 10 | 0 | 0 | 32 | Q1,Q2 | 3 | 3 |
| | | M-CGOB-008 Methods of targeting in molecular imaging | | | | | | | | | |
| | | M-CGOB-011 Méthodes de ciblage en imagerie moléculaire et applications biomédicales de l'imagerie moléculaire - Travaux personnels | | | | | | | | | |
| | UM-M1-BIOMED-027-M Techniques d'imagerie médicale: principe et applications | 22 | 0 | 10 | 0 | 0 | 32 | Q1,Q2 | 3 | 3 |
| | | M-CGOB-009 Techniques of molecular imaging | | | | | | | | | |
| | | M-CGOB-012 Techniques d'imagerie médicale: principe et applications - Travaux personnels | | | | | | | | | |
| | UM-M1-BIOMED-028-M Integrative Biomedicine | 41 | 0 | 0 | 0 | 0 | 41 | Q1 | 6 | 6 |
| | | M-DOYM-117 Brain & Immunity | | | | | | | | | |
| | | M-DOYM-118 Brain -Gut axis- | | | | | | | | | |
| | | M-DOYM-119 Neuro-endocrine System | | | | | | | | | |
| | | M-DOYM-120 Neurovascular Unit & BBB | | | | | | | | | |
| | UM-M1-BIOMED-029-M Research Techniques in Neuroscience | 45 | 0 | 0 | 0 | 0 | 45 | Q1 | 6 | 6 |
| | | M-DOYM-122 Research Techniques in Neuroscience | | | | | | | | | |
| | UM-M1-BIOMED-030-M Interdisciplinary Program in Healthcare Innovation | 30 | 0 | 0 | 0 | 0 | 30 | Q2 | 5 | 5 |
| | | M-PHPH-004 Interdisciplinary Program in Healthcare Innovation | | | | | | | | | |
| | UM-M1-BIOMED-036-M Brain Plasticity | 10 | 20 | 0 | 0 | 0 | 30 | Q1 | 4 | 4 |
| | | M-NEUR-121 Brain Plasticity | | | | | | | | | |
| | UM-M1-BIOMED-037-M Virologie | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | S-BIOG-156 Virology | | | | | | | | | |
| | UM-M1-BIOMED-038-M Tools to analyse brain function | 20 | 0 | 0 | 0 | 0 | 20 | Q2 | 3 | 3 |
| | | M-DOYM-050 Tools to analyse brain function | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| Enseignements complémentaires dédiés aux étudiants "passerelles" | | | | | | | | 0 | |
| | | | | | | | | | |
| | UM-M1-BIOMED-024-M Neuroanatomie et sémiologie neurologique | 36 | 15 | 0 | 0 | 0 | 51 | Q1 | 4 | 4 |
| | | M-NEUR-301 Neuroanatomy and Neurological Semiology | | | | | | | | | |
| | UM-M1-BIOMED-013-M Anatomie pathologique générale | 20 | 10 | 0 | 0 | 0 | 30 | Q1 | 3 | 3 |
| | | M-DOYM-040 General Anatomical Pathology | | | | | | | | | |
| | UM-M1-BIOMED-014-M Travaux personnels | 0 | 0 | 10 | 0 | 0 | 10 | Q1 | 5 | 5 |
| | | M-NEUR-111 Travaux personnels | | | | | | | | | |
| | UM-M1-BIOMED-015-M Stage en laboratoire | 0 | 0 | 40 | 0 | 0 | 40 | Q1 | 5 | 5 |
| | | M-NEUR-112 Stage en laboratoire | | | | | | | | | |
| | UM-M1-BIOMED-031-M Biochimie métabolique | 30 | 20 | 0 | 0 | 0 | 50 | Q1 | 3 | 3 |
| | | M-BIMO-201 Metabolic Biochemistry | | | | | | | | | |
| | UM-M1-BIOMED-032-M Pharmacologie générale | 20 | 0 | 0 | 0 | 0 | 20 | Q1 | 2 | 2 |
| | | M-CTPH-303 General Pharmacology | | | | | | | | | |
| | UM-M1-BIOMED-033-M Neurophysiologie des systèmes | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-NEUR-202 Systems Neurophysiology - part I | | | | | | | | | |
| | UM-M1-BIOMED-034-M Biologie moléculaire | 30 | 30 | 0 | 0 | 0 | 60 | Q2 | 3 | 3 |
| | | M-BIMO-204 Molecular biology | | | | | | | | | |
| | UM-M1-BIOMED-035-M Biologie cellulaire | 15 | 15 | 0 | 0 | 0 | 30 | Q2 | 2 | 2 |
| | | M-CGOB-302 Cellular biology | | | | | | | | | |
| | UM-M1-BIOMED-039-M Biochimie générale | 30 | 10 | 0 | 0 | 3 | 43 | Q2 | 4 | 4 |
| | | M-BIMO-101 General Biochemistry | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| Enseignements obligatoires spécifiques à la finalité approfondie | | | | | | | | 24 | |
| | | | | | | | | | |
| | UM-M1-BIOMFA-019-M Biologie intégrée - Aspects théoriques et pratiques | 35 | 40 | 0 | 0 | 0 | 75 | Q1,Q2 | 6 | 6 |
| | | S-BIOG-078 Integrated Biology (Genomics, Proteomics, Metabonomics) | | | | | | | | | |
| | | M-DOYM-041 Bioinformatics | | | | | | | | | |
| | | M-BIMO-004 Analyses intégratives de données variées | | | | | | | | | |
| | | M-DOYM-043 Biostatistics | | | | | | | | | |
| | UM-M1-BIOMFA-021-M Complément de biologie cellulaire | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-CGOB-010 Complement of cellular biology | | | | | | | | | |
| | UM-M1-BIOMFA-022-M Protéomie structurale et fonctionnelle | 20 | 0 | 20 | 0 | 0 | 40 | Q1,Q2 | 3 | 3 |
| | | S-BIOG-057 Structural and Functional Proteomics (part A) | | | | | | | | | |
| | | M-DOYM-111 Protéomie structurale et fonctionnelle - Travaux personnels | | | | | | | | | |
| | UM-M1-BIOMFA-023-M Thérapie génique: de la biologie moléculaire aux nouveaux médicaments personnalisés | 20 | 10 | 0 | 0 | 0 | 30 | Q1 | 3 | 3 |
| | | M-BIMO-003 Genic therapy: de la biologie moléculaire aux nouveaux médicaments personnalisés | | | | | | | | | |
| | UM-M1-BIOMFA-024-M Formation expérimentale au doctorat (3 mois) | 0 | 0 | 360 | 0 | 0 | 360 | Q2 | 10 | 10 |
| | | M-DOYM-033 Stage de préparation au mémoire | | | | | | | | | |
| | | M-DOYM-036 Préparation technique au mémoire | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | |
| | | | | | | | 60 | |
| | | | | | | | | |
Bloc 2 | Hours (*) | Term | Credits | Weight. |
| HT(*) | HTPE(*) | HTPS(*) | HD(*) | HR(*) | Total | |
| Enseignements obligatoires communs | | | | | | | | 40 | |
| | | | | | | | | | |
| | UM-M2-BIOMED-007-M Master Thesis | 0 | 0 | 360 | 0 | 0 | 360 | Q2 | 19 | 19 |
| | | M-DOYM-049 Master Thesis | | | | | | | | | |
| | UM-M2-BIOMED-008-M External Training | 0 | 0 | 360 | 0 | 0 | 360 | Q2 | 21 | 21 |
| | | M-DOYM-035 External Training | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| Enseignements optionnels communs | | | | | | | | 20 | |
| | | | | | | | | | |
| | UM-M2-BIOMED-001-M GMP-GLP-Validation | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-DOYM-012 GMP-GLP-Validation | | | | | | | | | |
| | UM-M2-BIOMED-002-M Intellectual Property | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-DOYM-003 Intellectual property | | | | | | | | | |
| | UM-M2-BIOMED-003-M Management Awareness of Technological Innovation Projects | 32 | 0 | 10 | 0 | 0 | 42 | Q1,Q2 | 4 | 4 |
| | | M-DOYM-034 Project management/Experimental design | | | | | | | | | |
| | | M-DOYM-115 Sensibilisation à la gestion de projets d'innovation technologique - Travaux personnels | | | | | | | | | |
| | UM-M2-BIOMED-011-M Neurotoxicology & Safety Pharmacology | 30 | 0 | 0 | 0 | 0 | 30 | Q1 | 4 | 4 |
| | | M-DOYM-129 Neurotoxicology and Safety Pharmacology | | | | | | | | | |
| | UM-M2-BIOMED-012-M Cellular Biology of Cancer | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-ANBC-004 Cellular Biology of Cancer | | | | | | | | | |
| | UM-M2-BIOMED-013-M Preclinical Models in Oncology | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-BIMO-028 Preclinical Models in Oncology | | | | | | | | | |
| | UM-M2-BIOMED-014-M Nuclear Receptors | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-DOYM-023 Nuclear Receptors | | | | | | | | | |
| | UM-M2-BIOMED-015-M Eléments d'immunologie clinique et expérimentale | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-DOYM-002 Elements of clinical and experimental immunology | | | | | | | | | |
| | UM-M2-BIOMED-016-M Histologie des organes des sens | 10 | 0 | 0 | 0 | 0 | 10 | Q1 | 2 | 2 |
| | | M-HIST-003 Histology of sense organs | | | | | | | | | |
| | UM-M2-BIOMED-017-M Neuropharmacology | 30 | 0 | 0 | 0 | 0 | 30 | Q1 | 4 | 4 |
| | | M-DOYM-026 Neuropharmacology | | | | | | | | | |
| | UM-M2-BIOMED-018-M Voies intracellulaires de communication et maladies métaboliques | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | M-BHTO-005 Voies intracellulaires de communication et maladies métaboliques | | | | | | | | | |
| | UM-M2-BIOMED-019-M Pharmacologie spéciale | 15 | 0 | 10 | 0 | 0 | 25 | Q1,Q2 | 2 | 2 |
| | | M-DOYM-042 Special pharmacology | | | | | | | | | |
| | | M-DOYM-114 Pharmacologie spéciale - Travaux personnels | | | | | | | | | |
| | UM-M2-BIOMED-020-M Méthodes de ciblage moléculaire et applications biomédicales de l'imagerie moléculaire | 22 | 0 | 10 | 0 | 0 | 32 | Q1,Q2 | 3 | 3 |
| | | M-CGOB-008 Methods of targeting in molecular imaging | | | | | | | | | |
| | | M-CGOB-011 Méthodes de ciblage en imagerie moléculaire et applications biomédicales de l'imagerie moléculaire - Travaux personnels | | | | | | | | | |
| | UM-M2-BIOMED-021-M Techniques d'imagerie médicale: principe et applications | 22 | 0 | 10 | 0 | 0 | 32 | Q1,Q2 | 3 | 3 |
| | | M-CGOB-009 Techniques of molecular imaging | | | | | | | | | |
| | | M-CGOB-012 Techniques d'imagerie médicale: principe et applications - Travaux personnels | | | | | | | | | |
| | UM-M2-BIOMED-022-M Integrative Biomedicine | 41 | 0 | 0 | 0 | 0 | 41 | Q1 | 6 | 6 |
| | | M-DOYM-117 Brain & Immunity | | | | | | | | | |
| | | M-DOYM-118 Brain -Gut axis- | | | | | | | | | |
| | | M-DOYM-119 Neuro-endocrine System | | | | | | | | | |
| | | M-DOYM-120 Neurovascular Unit & BBB | | | | | | | | | |
| | UM-M2-BIOMED-023-M Research Techniques in Neuroscience | 45 | 0 | 0 | 0 | 0 | 45 | Q1 | 6 | 6 |
| | | M-DOYM-122 Research Techniques in Neuroscience | | | | | | | | | |
| | UM-M2-BIOMED-025-M Brain Plasiticity | 10 | 20 | 0 | 0 | 0 | 30 | Q1 | 4 | 4 |
| | | M-NEUR-121 Brain Plasticity | | | | | | | | | |
| | UM-M2-BIOMED-026-M Virologie | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 |
| | | S-BIOG-156 Virology | | | | | | | | | |
| | UM-M2-BIOMED-027-M Tools to analyse brain function | 20 | 0 | 0 | 0 | 0 | 20 | Q2 | 3 | 3 |
| | | M-DOYM-050 Tools to analyse brain function | | | | | | | | | |
| | UM-M2-BIOMED-028-M Introduction to Computational Neuroscience | 20 | 0 | 0 | 0 | 0 | 20 | Q1 | 3 | 3 |
| | | M-DOYM-065 Introduction to Computational Neuroscience | | | | | | | | | |
| | UM-M2-BIOMED-029-M Basic Understanding of AI and BCI | 30 | 0 | 0 | 0 | 0 | 30 | Q1 | 4 | 4 |
| | | M-DOYM-066 Basic Understanding of AI and BCI | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| Enseignements obligatoires spécifiques à la finalité approfondie | | | | | | | | 6 | |
| | | | | | | | | | |
| | UM-M2-BIOMFA-001-M Approche transdisciplinaire des problèmes biomédicaux | 15 | 0 | 10 | 0 | 0 | 25 | Q1,Q2 | 2 | 2 |
| | | M-DOYM-048 Transdisciplinary approach to biomedical problems | | | | | | | | | |
| | | M-DOYM-112 Approche transdisciplinaire des problèmes biomédicaux - Travaux personnels | | | | | | | | | |
| | UM-M2-BIOMFA-002-M Évaluation du risque, étude d'impact sanitaire | 10 | 0 | 10 | 0 | 0 | 20 | Q1,Q2 | 2 | 2 |
| | | M-BHTO-002 Assessment of risk, medical impact study | | | | | | | | | |
| | | M-BHTO-111 Evaluation du risque, étude d'impact sanitaire - Travaux personnels | | | | | | | | | |
| | UM-M2-BIOMFA-003-M Vaccinologie | 15 | 0 | 10 | 0 | 0 | 25 | Q1,Q2 | 2 | 2 |
| | | M-DOYM-004 Vaccinology | | | | | | | | | |
| | | M-DOYM-116 Vaccinologie - Travaux personnels | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | |
| | | | | | | | 66 | |
| | | | | | | | | |